These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 23399651)

  • 101. Benign prostatic hyperplasia: dietary and metabolic risk factors.
    Nandeesha H
    Int Urol Nephrol; 2008; 40(3):649-56. PubMed ID: 18246440
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Obesity as a Risk Factor for Prostatic Enlargement: A Retrospective Cohort Study in Korea.
    Jung JH; Ahn SV; Song JM; Chang SJ; Kim KJ; Kwon SW; Park SY; Koh SB
    Int Neurourol J; 2016 Dec; 20(4):321-328. PubMed ID: 28043110
    [TBL] [Abstract][Full Text] [Related]  

  • 103. [Vitamin D deficiency, metabolic syndrome, and prostate adenoma: current epidemiological trends and pathophysiological mechanisms of interaction].
    Bratchikov OI; Artishchev SO; Tyuzikov IA
    Urologiia; 2018 Oct; (4):179-185. PubMed ID: 30761811
    [TBL] [Abstract][Full Text] [Related]  

  • 104. [Therapeutic usefulness of mepartricin in benign prostatic hypertrophy: 2 years' experience. Preliminary note on the effect of mepartricin on certain possible etiopathogenic factors in benign prostatic hypertrophy].
    Mirone V; Prezioso D; Palmieri A; Bocchini P
    Minerva Urol Nefrol; 1988; 40(2 Suppl):16-7. PubMed ID: 2460938
    [No Abstract]   [Full Text] [Related]  

  • 105. [Choice of hormone in prostate hypertrophy].
    GRIESSMANN ; DRUKE O
    Z Urol; 1955; 48(1):34-8. PubMed ID: 14375044
    [No Abstract]   [Full Text] [Related]  

  • 106. Fasting blood glucose level and hypertension risk in aging benign prostatic hyperplasia patients.
    Zi H; Wang XJ; Zhao MJ; Huang Q; Wang XH; Zeng XT
    Aging (Albany NY); 2019 Jul; 11(13):4438-4445. PubMed ID: 31280253
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Re: Vitamin D Deficiency as a Potential Marker of Benign Prostatic Hyperplasia.
    Kaplan SA
    J Urol; 2018 Nov; 200(5):919-920. PubMed ID: 30360296
    [No Abstract]   [Full Text] [Related]  

  • 108. Current evidence for the involvement of sex steroid receptors and sex hormones in benign prostatic hyperplasia.
    Da Silva MHA; De Souza DB
    Res Rep Urol; 2019; 11():1-8. PubMed ID: 30662879
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Unprecedentedly High Level of Intracellular Vitamin C and DNA Epigenetic Marks in Prostate: Relevant for Male Fertility?
    Guz J; Zarakowska E; Mijewski P; Wasilow A; Szpotan J; Foksinski M; Brzoszczyk B; Gackowski D; Jarzemski P; Olinski R
    Cell Physiol Biochem; 2023 Jun; 57(4):200-211. PubMed ID: 37463420
    [TBL] [Abstract][Full Text] [Related]  

  • 110. [The role of obesity in the pathogenesis of benign prostatic hyperplasia].
    Bratchikov OI; Tyuzikov IA; Artishchev SO; Shumakova EA
    Urologiia; 2020 Apr; (2):101-106. PubMed ID: 32351071
    [TBL] [Abstract][Full Text] [Related]  

  • 111. [Pathogenesis of benign prostatic hyperplasia from the perspective of syndrome differentiation of viscera based on the neuro-endocrine-immune network].
    Hu RL; Wang XY; Zhang T; Zhao WJ
    Zhonghua Nan Ke Xue; 2024 Mar; 30(3):261-265. PubMed ID: 39177394
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Ultrasonographic measurement of the prostatic dimension-to-aortic luminal diameter in healthy intact male dogs and dogs with benign prostatic hyperplasia.
    Ponglowhapan S; Pattanaviboon K; Maneerattanavichien Y; Phitchayangkoon P; Lueangprasert P; Preechatangkit A; Suthigarn S; Saisawart P; Thanaboonnipat C; Choisunirachon N
    J Small Anim Pract; 2024 Aug; ():. PubMed ID: 39138586
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Prostaglandins and the prostate: an hypothesis on the etiology of benign prostatic hyperplasia.
    Klein LA; Stoff JS
    Prostate; 1983; 4(3):247-51. PubMed ID: 6189107
    [No Abstract]   [Full Text] [Related]  

  • 114. [Hormone therapy of prostate adenoma].
    J Med Bord; 1953 Jul; 130(7):902. PubMed ID: 13097008
    [No Abstract]   [Full Text] [Related]  

  • 115. Hemato-biochemical alterations and urinalysis in dogs suffering from benign prostatic hyperplasia.
    Das MR; Patra RC; Das RK; Rath PK; Mishra BP
    Vet World; 2017 Mar; 10(3):331-335. PubMed ID: 28435196
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Metabolic syndrome components and prostatic hyperplasia among diabetic and non-diabetic men in the Eastern DR Congo: A cross-sectional study.
    Mubenga LE; Gruson D; Hermans MP; Bwenge E; Tombal B
    Diabetes Metab Syndr; 2019; 13(1):776-780. PubMed ID: 30641805
    [No Abstract]   [Full Text] [Related]  

  • 117. Electrophoretic evaluation of different hormonal receptor sites in the prostate during anti-hormonal treatment and in response to hormones.
    Fischer DR; Gevers W
    Urol Int; 1979; 34(2):95-104. PubMed ID: 87051
    [TBL] [Abstract][Full Text] [Related]  

  • 118. [Liver and prostatic adenoma].
    Francone E; Gallizia G
    Epatologia; 1970; 16(1):91-4. PubMed ID: 4112410
    [No Abstract]   [Full Text] [Related]  

  • 119. Sugar neuropathy and phlebomalacia--can they cause benign prostatic enlargement and diabetes mellitus?
    Daynes WG
    S Afr Med J; 1973 Feb; 47(8):318-9. PubMed ID: 4120786
    [No Abstract]   [Full Text] [Related]  

  • 120. Re: The Association between Triglyceride High Density Lipoprotein Cholesterol Ratio and Benign Prostate Hyperplasia in Non-Diabetic Patients:
    Kaplan SA
    J Urol; 2019 Feb; 201(2):203-204. PubMed ID: 30634296
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.